Main Industry
Health Care
Main Product/Service
Domestic development and marketing of health foods in Taiwan (including patented natural kefir-fermented functional peptide health foods, lactoferrin products, and other health foods), as well as the international marketing of kefir-fermented functional peptide health products.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2015
Unified Business No.
24784137
Status
Active
Number of Employees
0
Total Paid-in
Capital
80,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Currently, the global population aging trend is prominent, and Taiwan is also about to enter an aged society. The prevalence of chronic and metabolic diseases among citizens is rising year by year, and the medical burden derived from the elderly population is increasing accordingly. In view of this, China Chemical & Pharmaceutical Co., Ltd., with a foundation of over 60 years, upholds the philosophy of "rooting in professionalism, moving forward for health," actively dedicating itself to the health food industry for sub-healthy populations and the silver-haired elderly, and integrating group resources to construct "comprehensive health services." Over the years, it has collaborated with academic and medical experts to form industry-academic teams, dedicating itself to the research and development of novel health ingredients. The scientific validation of its efficacy research has not only been published in well-known international journals, but the patent layout of its key technologies has also been fully established.
Therefore, to quickly enter the market and expand its business scope into the health food and preventive medicine industries, PHERMPEP CO., LTD. was established in 2015 as a subsidiary of China Chemical & Pharmaceutical affiliates specializing in the research, development, and production of novel health ingredients. With "the application and development of functional peptides in the fields of preventive medicine and pharmaceuticals" as its core technology, it provides health-promoting products and services. By appointing academic experts with rich R&D experience as company executives, and organizing a management and cooperation team covering fields such as R&D, production, marketing, and intellectual property regulations, the company aims to become a leader in health and biomedical industry technology and a creator of the soft economy through practical approaches such as technological advancement, cross-disciplinary integration, and value extension.
(The content above was translated by AI.)
Therefore, to quickly enter the market and expand its business scope into the health food and preventive medicine industries, PHERMPEP CO., LTD. was established in 2015 as a subsidiary of China Chemical & Pharmaceutical affiliates specializing in the research, development, and production of novel health ingredients. With "the application and development of functional peptides in the fields of preventive medicine and pharmaceuticals" as its core technology, it provides health-promoting products and services. By appointing academic experts with rich R&D experience as company executives, and organizing a management and cooperation team covering fields such as R&D, production, marketing, and intellectual property regulations, the company aims to become a leader in health and biomedical industry technology and a creator of the soft economy through practical approaches such as technological advancement, cross-disciplinary integration, and value extension.
(The content above was translated by AI.)
